Anbio Biotechnology Class A Ordinary Shares
NNNN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 21.9% | -71.5% | 431.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 71.9% | 50.1% | 53.4% | 57.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 31.4% | 33.8% | 42.6% | 57.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 29% | 33.6% | 42.5% | 57.3% |
| EPS Diluted | 0.056 | 0.012 | 0.07 | 0.025 |
| % Growth | 366.7% | -82.8% | 174% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |